Mineralys Therapeutics (MLYS) Non-Current Assets (2022 - 2026)
Mineralys Therapeutics' Non-Current Assets came in at $2.13 million for Q3 2026, compared with $151,000 a year earlier and up 3.8% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Mineralys Therapeutics' Non-Current Assets was $420,000, down 23.9% from FY2024.
- Non-Current Assets carries a three-year compound annual growth rate of -36.4% (FY2022 to FY2025).
- Going back by year, Non-Current Assets was $552,000 in FY2024 (-78.2%), $2.53 million in FY2023 (+55.3%) and $1.63 million in FY2022.
- The Q3 2026 figure represents the highest quarterly Non-Current Assets since Q4 2023.
- Year-over-year, Non-Current Assets increased in two of the last seven quarters, with growth averaging 23.1%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q2 2026 (growth of 350.8%), and the weakest in Q1 2024 (a decline of 98.6%).
- Business Quant data shows MLYS's Non-Current Assets at $2.05 million (Q2 2026), $392,000 (Q1 2026) and $420,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Mineralys Therapeutics | 1.42 Bn | -1.17 Bn | - | 2.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.13 Mn |
| Jun 30, 2026 | 2.05 Mn |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | 420,000.00 |
| Sep 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 455,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | 552,000.00 |
| Sep 30, 2024 | 521,000.00 |
| Jun 30, 2024 | 491,000.00 |
| Mar 31, 2024 | 430,000.00 |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 12.18 Mn |
| Jun 30, 2023 | 21.73 Mn |
| Mar 31, 2023 | 31.16 Mn |
| Dec 31, 2022 | 1.63 Mn |
API Access
Mineralys Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();